维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="Zonder JA"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Melphalan and dexamethasone plus bortezomib induces hematologic and organ responses in AL-amyloidosis with tolerable neurotoxicity 显示文摘	Zonder JA Sanchorawala V Snyder RM	2009	Blood (ASH Annual Meeting Abstracts)2009，114，：	1
	2	Clinical development of novel proteasome inhibitors for cancer treatment 显示文摘	Yang H Zonder JA Dou QP	2009	Expert Opin Investig Drugs2009，18，7：	1
	3	Pharmacology and clinical experience with bryostatin 1: a novel anticancer drug 显示文摘	Philip PA Zonder JA	1999	Expert Opin Investig Drags1999，8，12：	1
	4	Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone:benefit of aspirin prophylaxis显示文摘	Zonder JA Barlogie B Durie BG	2006	Blood2006，108，1：	1
	5	A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced muhiple myeloma 显示文摘	Zonder JA Mohrbaeher AF Singhal S	2012	Blood2012，120，3：	1
	6	The effect of dose increase of imatinib mesylate in patients with chronic or accelerated phase chronic myelogenous leukemia with inadequate hematologic or cytogenetic response to initial treatment显示文摘	Zonder JA Pemberton P Brandt H	2003	Clin Cancer Res2003，9，6：	1
	7	Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis显示文摘	Zonder JA Barlogie B Durie BG	2006	Blood2006，108，1：	1
	8	A phase Ⅱ trial of bryostatin 1 in the treatment of metastatic colorectal cancer显示文摘	Zonder JA Shields AF Zalupski M	2001	Clin Cancer Res2001，7，1：	1
	9	A phase Ⅱ trial of bryostatin 1 in the treatment of metastatic colorectal cancer 显示文摘	Zonder JA Shields AW Zalupski M	2001	Clin Cancer Res2001，7，1：	1
	10	Clinical development of novel proteasome inhibitors for cancer treatment显示文摘	YANG H ZONDER JA DOU QP	2009	Expert Opin Investig Drugs2009，18，7：	1
	11	Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial thera-py for multiple myeloma:a randomized Southwest Oncology Grouptrial(S0232)显示文摘	Zonder JA Crowley J Hussein MA	2010	Blood2010，116，26：	1
	12	Thrombotic complications in pa-tients with newly diagnosed multiple myeloma treated with lenalido-mide and dexamethasone:Benefit of aspirin prophy-laxis显示文摘	Zonder JA Barlogie B Durie BG	2006	Blood2006，108，1：	1
	13	Pharmacology and clinical experience with bryostatin 1: a novel anticancer drug显示文摘	Philip PA Zonder JA	1999	Expert Opin Investig Drugs1999，8，：	1
	14	A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma显示文摘	ZONDER JA MOHRBACHER AF SINGHAL S	2012	Blood2012，120，3：	1
	15	Thrombotic complicationsin patients with newly diagnosed multiple myeloma treated with le-nalidomide and dexamethasone:benefit of aspirin prophylaxis显示文摘	Zonder JA Barlogie B Dune BG	2006	Blood2006，108，：	1
	16	Clinical development of novel proteasome inbibitors for cancer treatment 显示文摘	Yang HJ Zonder JA Dou QP	2009	Expert Opin Inv Drug2009，18，7：	1
	17	Lenalidomide and high-dose dexamethasone comapared with dexamethasone as initial thera-py for multiple myeloma:a randomized Southwest Ontology Group trial (S0232) 显示文摘	Zonder JA Crowley J Hussein MA	2010	Blood2010，116，26：	1
	18	Clinical development of novel pro- teasome inhibitors for cancer treatment 显示文摘	Yang H Zonder JA Dou QP	2009	Expert Opin Investig Drugs2009，18，7：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费